128.86
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Reata Pharmaceuticals Inc | RETA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 128.86 | 0.00 | 0.00 | 0.00 | 128.86 | 08:40:59 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 129.00 | 151.51 | 22.51 | 14.86% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 128.86 | USD |
Reata Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 4.28B | 33.23M | $ -80.55M | -9.54 | - | 32.93M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 9.00 | 0.90% |
Reata Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RETA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 151.91 | 162.0449 | 126.10 | 139.33 | 440,960 | -23.05 | -15.17% |
| 1 Month | 171.20 | 182.93 | 113.01 | 143.34 | 478,581 | -42.34 | -24.73% |
| 3 Months | 203.02 | 257.965 | 113.01 | 185.05 | 422,553 | -74.16 | -36.53% |
| 6 Months | 80.40 | 257.965 | 75.67 | 184.51 | 503,190 | 48.46 | 60.27% |
| 1 Year | 90.55 | 257.965 | 70.00 | 154.84 | 365,953 | 38.31 | 42.31% |
| 3 Years | 22.43 | 257.965 | 19.31 | 97.97 | 274,526 | 106.43 | 474.5% |
| 5 Years | 11.06 | 257.965 | 11.03 | 90.81 | 235,523 | 117.80 | 1,065.1% |
Reata Pharmaceuticals Description
| Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others. |
